Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study

IntroductionImmune checkpoint inhibitors (ICIs) have transformed advanced gastric cancer treatment, yet patient responses vary, highlighting the need for effective biomarkers. Common markers, such as programmed cell death ligand-1 (PD-L1), microsatellite instability/mismatch repair (MSI/MMR), tumor...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yuanyuan Yang, Zhe Wang, Dao Xin, Lulu Guan, Bingtong Yue, Qifan Zhang, Feng Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-10-01
Edice:	Frontiers in Immunology
Témata:	PD-1/PD-L1 inhibitors gastric or gastroesophageal junction cancer predictive biomarkers prognosis efficacy
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1468342/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!